 |
|
Stem cell research aims to tackle Parkinson's disease
January 21, 2008New ways to grow brain cells in the laboratory could eventually provide a way to treat Parkinson's disease
Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinson's disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.
Professor Ernest Arenas of the Karolinska Institute in Stockholm presented his research to the EuroSTELLS "Stem Cell Niches" conference in Barcelona on January 11. Stem cell therapy hold the promise of treating disease by growing new tissues and organs from stem cells - 'blank' cells that have the potential to develop into fully mature or 'differentiated' cells. The EuroSTELLS is an ESF EURCORES programme, managed by the European Medical Research Councils (EMRC), that aims to develop a stem cell 'toolbox' by generating fundamental knowledge on stem cell biology.
Parkinson's disease affects around three in a hundred of people aged over 65. The condition can cause muscles to become rigid and limbs to tremble uncontrollably. Parkinson's disease results from the loss of a particular type of brain cell called dopaminergic (DA) neurons in the part of the brain called the substantia nigra.
Among the various approaches that are currently being discussed from an ethical perspective, is the possible approach of taking stem cells, growing them into new brain cells and transplanting these into the patient. "The idea is to start with stem cells and induce them to become neurons," said Professor Arenas, whose research is carried out as part of a EuroSTELLS collaboration. "These could then be transplanted into the brain of the patient. Also, such cells could be ideal for developing and testing new drugs to treat brain disease."
However, to create such cells that function efficiently and safely is a major challenge. Early efforts at growing DA neurons from embryonic stem cells produced cells which, when transplanted into animal models, had a tendency to form tumours or clumps, or die without an obvious reason.
Professor Arenas's team studied the development of DA neurons in animals to determine the important biological molecules in the brain that were necessary for the cells to grow and function efficiently. The scientists identified one particular molecule that seemed to be key, a protein called Wnt5a. They showed that when this molecule, together with a second protein called noggin, was included in cultures of stem cells, far more DA neurons were produced than when these ingredients were not present.
The team then carried out a series of molecular, chemical and electrophysiological tests on the newly grown neurons to check their proficiency, which was shown to be good.
Crucially the team also moved away from embryonic stem cells - which can be induced to grow into a wide variety of different cells. Instead they used neural stem cells - which are programmed to develop only into nerve cells.
When the researchers transplanted the cells into laboratory animals whose substantia nigra region of the brain was damaged, the results were promising. "We reversed almost completely the behavioural abnormalities, and neurons differentiated, survived and re-innervated the relevant part of the brain better" Professor Arenas said. "Furthermore we do not see the kind of proliferation of the cells that has occurred in the past and we get very little clustering when the cells are treated with Wnt5a. The cells are safer than embryonic stem cells and more efficient than fetal tissue."
Verification of this approach with human cells is ongoing and if the study is successful, it may lead to a clinical trial. Experts in the field have recently identified this approach as the next step in cell replacement therapy for Parkinson's disease and the hope is that this may, ultimately, lead to cells suitable for transplant into human patients.
European Science Foundation
Parkinson's disease affects around three in a hundred of people aged over 65. The condition can cause muscles to become rigid and limbs to tremble uncontrollably. Parkinson's disease results from the loss of a particular type of brain cell called dopaminergic (DA) neurons in the part of the brain called the substantia nigra.
Among the various approaches that are currently being discussed from an ethical perspective, is the possible approach of taking stem cells, growing them into new brain cells and transplanting these into the patient. "The idea is to start with stem cells and induce them to become neurons," said Professor Arenas, whose research is carried out as part of a EuroSTELLS collaboration. "These could then be transplanted into the brain of the patient. Also, such cells could be ideal for developing and testing new drugs to treat brain disease."
However, to create such cells that function efficiently and safely is a major challenge. Early efforts at growing DA neurons from embryonic stem cells produced cells which, when transplanted into animal models, had a tendency to form tumours or clumps, or die without an obvious reason.
Professor Arenas's team studied the development of DA neurons in animals to determine the important biological molecules in the brain that were necessary for the cells to grow and function efficiently. The scientists identified one particular molecule that seemed to be key, a protein called Wnt5a. They showed that when this molecule, together with a second protein called noggin, was included in cultures of stem cells, far more DA neurons were produced than when these ingredients were not present.
The team then carried out a series of molecular, chemical and electrophysiological tests on the newly grown neurons to check their proficiency, which was shown to be good.
Crucially the team also moved away from embryonic stem cells - which can be induced to grow into a wide variety of different cells. Instead they used neural stem cells - which are programmed to develop only into nerve cells.
When the researchers transplanted the cells into laboratory animals whose substantia nigra region of the brain was damaged, the results were promising. "We reversed almost completely the behavioural abnormalities, and neurons differentiated, survived and re-innervated the relevant part of the brain better" Professor Arenas said. "Furthermore we do not see the kind of proliferation of the cells that has occurred in the past and we get very little clustering when the cells are treated with Wnt5a. The cells are safer than embryonic stem cells and more efficient than fetal tissue."
Verification of this approach with human cells is ongoing and if the study is successful, it may lead to a clinical trial. Experts in the field have recently identified this approach as the next step in cell replacement therapy for Parkinson's disease and the hope is that this may, ultimately, lead to cells suitable for transplant into human patients.
European Science Foundation
More Parkinson’s Disease News Articles
 | Life in the Balance: A Physician's Memoir of Life, Love, and Loss with Parkinson's Disease and Dementia by Thomas Graboys, Peter Zheutlin At the age of 49, Dr. Thomas Graboys had reached the pinnacle of his career and was leading a charmed life. A nationally renowned Boston cardiologist popular for his attention to the hearts and souls of his patients, Graboys was part of “The Cardiology Dream Team” summoned to treat Boston Celtics star Reggie Lewis after he collapsed on the court in 1993. He had a beautiful wife, two... |
 | Delay the Disease -Exercise and Parkinson's Disease by David Zid David Zid, an ACE, APG certified trainer, has collaborated with orthopedic surgeon, Thomas H. Mallory, M.D., who is afflicted with Parkinson's disease, in the development of a Parkinson's specific fitness program designed to proactively minimize tremors and improve flexibility, stability, balance and strength. Delay the Disease contains colorful photographs of Zid demonstrating each move, as well... |
 | Parkinson's Disease: 300 Tips for Making Life Easier by Shelley Peterman Schwarz Being diagnosed with Parkinson's disease can be distressing, and adjusting to the effects of the disease is often difficult. This indispensable resource for patients, family, friends, and caregivers helps patients rise above PD’s challenges by working smarter, maintaining a positive outlook, and conserving time and energy. Organized by subject, the book covers a wide range of topics,... |
 | Parkinson's Disease: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book) by William J. Weiner, Lisa M. Shulman, Anthony E. Lang Recent innovations, including deep brain stimulation and new medications, have significantly improved the lives of people with Parkinson's disease. Nevertheless, medical, emotional, and physical challenges remain. The second edition of this accessible and comprehensive guide provides crucial information for managing this complex condition, including details on the use of medications, diet,... |
 | The New Yoga for Healthy Aging: Living Longer, Living Stronger and Loving Every Day by Suza Francina, Jim Jacobs Photographer A step-by-step guide for the millions of baby boomers who want one simple practice for feeling and looking great—yoga! One in five Americans is now moving toward the age bracket of "sixty and beyond," and while many are calling sixty the "new forty," this milestone is the perfect time to take stock in good health. One form of exercise that is proven to prevent or alleviate a host of physical... |
 | Parkinson's Disease & the Art of Moving by John Argue Faced with an incurable and often debilitating illness, Parkinson's patients must relearn how to sit up in a chair, speak clearly, keep their balance while walking, and stand from a sitting position. Over 100 photographs illustrate exercises derived from yoga and t'ai chi techniques; and theater movement skills show readers how to cope as gracefully as possible with the loss of coordination that... |
 | The Oxygen Revolution: Hyperbaric Oxygen Therapy: The Groundbreaking New Treatment for Stroke, Alzheimer's, Parkinson's, Arthritis, Autism, Learning Disabilities and More by Paul G. Harch, Virginia Mccullough HOPE FOR MANY "HOPELESS" DISEASES, FROM ONE OF THE FOREMOST RESEARCHERS IN THE FIELDWhen Randy McCloy, Jr., the sole survivor of the Sago Mine disaster, finally walked out of the hospital to rejoin his family, it was in part due to the miracle of hyperbaric oxygen therapy. Hyperbaric oxygen therapy (HBOT) is based on an almost laughably simple idea: Oxygen can be used therapeutically for a wide... |
 | Parkinson's Disease For Dummies (For Dummies (Health & Fitness)) by Michele Tagliati, Gary Guten, Jo Horne If you or someone you love has been diagnosed with Parkinson’s Disease you’re probably wrestling with fear, despair, and countless questions about the future. It’s brighter than you think. In Parkinson’s Disease for Dummies, you’ll discover how to keep a positive attitude and lead an active, productive life as this user-friendly, guide pilots you through the... |
 | Lucky Man: A Memoir by Michael J. Fox The same sharp intelligence and self-deprecating wit that made Michael J. Fox a star in the Family Ties TV series and Back to the Future make this a lot punchier than the usual up-from-illness celebrity memoir. Yes, he begins with the first symptoms of Parkinson's disease, the incurable illness that led to his retirement from Spin City (and acting) in 2000. And yes, he assures us he is a... |
 | Awakenings by Oliver Sacks It hardly seems fair that so many great doctors are also great writers. Perhaps it's qualities like sensitivity, craft, and dedication that keep physicians like Oliver Sacks in hospitals all day and at writing desks all night; if nothing else, these qualities shine in books like Awakenings. This powerful set of case histories rises above its pathological foundation to find new literary territory,... |
| © 2008 BrightSurf.com |